Acute kidney injury and C. diff infection are costly problems for hospitals and healthcare systems. These conditions are associated with poorer patient outcomes, including increased mortality and longer length of hospital stay.
The COVID-19 pandemic poses a threat to our antibiotic infrastructure, which is already compromised due to a lack of new therapies. That threat makes antimicrobial stewardship even more important.
“We have found that deep-sea microorganisms, especially actinomycetes, are an attractive, untapped source for the discovery of anti-infective agents,” said Guojun Wang, Ph.D., assistant research professor at FAU Harbor Branch.